$RCAT
Red Cat Holdings, Inc.

2024 Q4 Form 10-Q Financial Statement

#000155479524000344 Filed on December 16, 2024

View on sec.gov

Income Statement

Concept 2024 Q4
Revenue $1.535M
YoY Change -60.96%
Cost Of Revenue $1.558M
YoY Change -42.93%
Gross Profit -$23.48K
YoY Change -101.96%
Gross Profit Margin -1.53%
Selling, General & Admin
YoY Change
% of Gross Profit
Research & Development $2.231M
YoY Change 12.25%
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses $9.093M
YoY Change 57.86%
Operating Profit -$13.33M
YoY Change 192.45%
Interest Expense -$14.63K
YoY Change -174.3%
% of Operating Profit
Other Income/Expense, Net -$4.218M
YoY Change 1174.0%
Pretax Income -$9.116M
YoY Change 99.94%
Income Tax
% Of Pretax Income
Net Earnings -$13.33M
YoY Change 134.71%
Net Earnings / Revenue -868.86%
Basic Earnings Per Share
Diluted Earnings Per Share
COMMON SHARES
Basic Shares Outstanding 80.16M shares
Diluted Shares Outstanding

Balance Sheet

Concept 2024 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments
YoY Change
Cash & Equivalents $4.611M
Short-Term Investments
Other Short-Term Assets $3.015M
YoY Change 6.18%
Inventory $12.17M
Prepaid Expenses $2.626M
Receivables $1.121M
Other Receivables
Total Short-Term Assets $20.91M
YoY Change -10.1%
LONG-TERM ASSETS
Property, Plant & Equipment $1.973M
YoY Change -23.17%
Goodwill $22.96M
YoY Change 34.98%
Intangibles $3.440M
YoY Change -50.06%
Long-Term Investments
YoY Change
Other Assets $309.8K
YoY Change 2.19%
Total Long-Term Assets $30.18M
YoY Change 10.37%
TOTAL ASSETS
Total Short-Term Assets $20.91M
Total Long-Term Assets $30.18M
Total Assets $51.09M
YoY Change 0.96%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $1.591M
YoY Change -1.66%
Accrued Expenses $1.432M
YoY Change 122.61%
Deferred Revenue $221.4K
YoY Change 258.19%
Short-Term Debt $357.0K
YoY Change -62.58%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $14.67M
YoY Change 233.07%
LONG-TERM LIABILITIES
Long-Term Debt
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $9.392M
YoY Change 2776.43%
TOTAL LIABILITIES
Total Short-Term Liabilities $14.67M
Total Long-Term Liabilities $9.392M
Total Liabilities $24.06M
YoY Change 408.57%
SHAREHOLDERS EQUITY
Retained Earnings -$106.9M
YoY Change 61.75%
Common Stock $78.03K
YoY Change 40.21%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $27.03M
YoY Change
Total Liabilities & Shareholders Equity $51.09M
YoY Change 0.96%

Cashflow Statement

Concept 2024 Q4
OPERATING ACTIVITIES
Net Income -$13.33M
YoY Change 134.71%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities
YoY Change
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities
YoY Change
NET CHANGE
Cash From Operating Activities
Cash From Investing Activities
Cash From Financing Activities
Net Change In Cash
YoY Change
FREE CASH FLOW
Cash From Operating Activities
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023Q3 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
usd
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2025
dei Entity Small Business
EntitySmallBusiness
true
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--04-30
dei Entity Central Index Key
EntityCentralIndexKey
0000748268
dei Amendment Flag
AmendmentFlag
false
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
CY2024Q4 us-gaap Equity Method Investments
EquityMethodInvestments
usd
CY2024Q4 us-gaap Long Term Accounts Notes And Loans Receivable Net Noncurrent
LongTermAccountsNotesAndLoansReceivableNetNoncurrent
usd
CY2024Q2 us-gaap Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
usd
CY2024Q2 us-gaap Asset Acquisition Contingent Consideration Liability Current
AssetAcquisitionContingentConsiderationLiabilityCurrent
usd
CY2024Q2 us-gaap Convertible Long Term Notes Payable
ConvertibleLongTermNotesPayable
usd
CY2024Q4 us-gaap Impairment Of Intangible Assets Excluding Goodwill
ImpairmentOfIntangibleAssetsExcludingGoodwill
usd
CY2023Q4 us-gaap Impairment Of Intangible Assets Excluding Goodwill
ImpairmentOfIntangibleAssetsExcludingGoodwill
usd
us-gaap Impairment Of Intangible Assets Excluding Goodwill
ImpairmentOfIntangibleAssetsExcludingGoodwill
usd
CY2023Q4 RCAT Convertible Notes Payable Fair Value Adjustment
ConvertibleNotesPayableFairValueAdjustment
usd
RCAT Convertible Notes Payable Fair Value Adjustment
ConvertibleNotesPayableFairValueAdjustment
usd
CY2024Q4 us-gaap Equity Method Investment Realized Gain Loss On Disposal
EquityMethodInvestmentRealizedGainLossOnDisposal
usd
CY2023Q4 us-gaap Equity Method Investment Realized Gain Loss On Disposal
EquityMethodInvestmentRealizedGainLossOnDisposal
usd
us-gaap Equity Method Investment Realized Gain Loss On Disposal
EquityMethodInvestmentRealizedGainLossOnDisposal
usd
CY2024Q4 us-gaap Gain Loss On Sale Of Stock In Subsidiary Or Equity Method Investee
GainLossOnSaleOfStockInSubsidiaryOrEquityMethodInvestee
usd
CY2023Q4 us-gaap Gain Loss On Sale Of Stock In Subsidiary Or Equity Method Investee
GainLossOnSaleOfStockInSubsidiaryOrEquityMethodInvestee
usd
us-gaap Gain Loss On Sale Of Stock In Subsidiary Or Equity Method Investee
GainLossOnSaleOfStockInSubsidiaryOrEquityMethodInvestee
usd
CY2024Q4 us-gaap Investment Income Net
InvestmentIncomeNet
usd
us-gaap Investment Income Net
InvestmentIncomeNet
usd
us-gaap Other Nonrecurring Income Expense
OtherNonrecurringIncomeExpense
usd
CY2024Q4 us-gaap Income Loss From Discontinued Operations Net Of Tax
IncomeLossFromDiscontinuedOperationsNetOfTax
usd
us-gaap Income Loss From Discontinued Operations Net Of Tax
IncomeLossFromDiscontinuedOperationsNetOfTax
usd
CY2024Q4 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Before Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent
usd
CY2024Q4 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
usd
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
usd
CY2024Q4 RCAT Earnings Per Share Basic And Diluted Discontinued Operations Rcat
EarningsPerShareBasicAndDilutedDiscontinuedOperationsRCAT
RCAT Earnings Per Share Basic And Diluted Discontinued Operations Rcat
EarningsPerShareBasicAndDilutedDiscontinuedOperationsRCAT
CY2024Q3 RCAT Stock Issued During Period Value Stock Warrants Exercised
StockIssuedDuringPeriodValueStockWarrantsExercised
usd
CY2024Q4 RCAT Stock Issued During Period Value Stock Warrants Exercised
StockIssuedDuringPeriodValueStockWarrantsExercised
usd
RCAT Income Loss From Discontinued Operations
IncomeLossFromDiscontinuedOperations
usd
us-gaap Marketable Securities Gain Loss
MarketableSecuritiesGainLoss
usd
us-gaap Equity Method Investment Realized Gain Loss On Disposal
EquityMethodInvestmentRealizedGainLossOnDisposal
usd
us-gaap Gain Loss On Sale Of Stock In Subsidiary Or Equity Method Investee
GainLossOnSaleOfStockInSubsidiaryOrEquityMethodInvestee
usd
us-gaap Impairment Of Intangible Assets Excluding Goodwill
ImpairmentOfIntangibleAssetsExcludingGoodwill
usd
RCAT Convertible Notes Payable Fair Value Adjustment
ConvertibleNotesPayableFairValueAdjustment
usd
us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
usd
us-gaap Proceeds From Sale Of Equity Method Investments
ProceedsFromSaleOfEquityMethodInvestments
usd
us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
usd
us-gaap Proceeds From Issuance Or Sale Of Equity
ProceedsFromIssuanceOrSaleOfEquity
usd
us-gaap Cash Provided By Used In Operating Activities Discontinued Operations
CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations
usd
us-gaap Cash Provided By Used In Investing Activities Discontinued Operations
CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations
usd
us-gaap Cash Provided By Used In Investing Activities Discontinued Operations
CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations
usd
us-gaap Cash Provided By Used In Financing Activities Discontinued Operations
CashProvidedByUsedInFinancingActivitiesDiscontinuedOperations
usd
us-gaap Net Cash Provided By Used In Discontinued Operations
NetCashProvidedByUsedInDiscontinuedOperations
usd
CY2024Q4 us-gaap Disposal Group Including Discontinued Operation Cash
DisposalGroupIncludingDiscontinuedOperationCash
usd
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
usd
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
usd
us-gaap Stock Issued During Period Value Acquisitions
StockIssuedDuringPeriodValueAcquisitions
usd
us-gaap Business Combination Consideration Transferred1
BusinessCombinationConsiderationTransferred1
usd
us-gaap Noncash Or Part Noncash Acquisition Net Nonmonetary Assets Acquired Liabilities Assumed1
NoncashOrPartNoncashAcquisitionNetNonmonetaryAssetsAcquiredLiabilitiesAssumed1
usd
us-gaap Other Comprehensive Income Availableforsale Securities Adjustment Before Tax Portion Attributable To Parent
OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentBeforeTaxPortionAttributableToParent
usd
RCAT Conversion Of Preferred Stock Into Common Stock
ConversionOfPreferredStockIntoCommonStock
usd
CY2024Q2 RCAT Fair Value Level3 Convertible Notes Payable Balance
FairValueLevel3ConvertibleNotesPayableBalance
usd
CY2024Q4 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
usd
us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Before Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent
-4621 usd
us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
-25750994 usd
us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-12487713 usd
CY2024Q4 us-gaap Disposal Group Including Discontinued Operation Revenue
DisposalGroupIncludingDiscontinuedOperationRevenue
usd
us-gaap Disposal Group Including Discontinued Operation Revenue
DisposalGroupIncludingDiscontinuedOperationRevenue
usd
CY2024Q4 us-gaap Disposal Group Including Discontinued Operation Costs Of Goods Sold
DisposalGroupIncludingDiscontinuedOperationCostsOfGoodsSold
usd
us-gaap Disposal Group Including Discontinued Operation Costs Of Goods Sold
DisposalGroupIncludingDiscontinuedOperationCostsOfGoodsSold
usd
CY2024Q4 us-gaap Disposal Group Including Discontinued Operation Gross Profit Loss
DisposalGroupIncludingDiscontinuedOperationGrossProfitLoss
usd
us-gaap Disposal Group Including Discontinued Operation Gross Profit Loss
DisposalGroupIncludingDiscontinuedOperationGrossProfitLoss
usd
CY2024Q4 RCAT Disposal Group Including Discontinued Operation Research And Development Expense
DisposalGroupIncludingDiscontinuedOperationResearchAndDevelopmentExpense
usd
RCAT Disposal Group Including Discontinued Operation Research And Development Expense
DisposalGroupIncludingDiscontinuedOperationResearchAndDevelopmentExpense
usd
CY2024Q4 RCAT Disposal Group Including Discontinued Operation Sales And Marketing Expense
DisposalGroupIncludingDiscontinuedOperationSalesAndMarketingExpense
usd
RCAT Disposal Group Including Discontinued Operation Sales And Marketing Expense
DisposalGroupIncludingDiscontinuedOperationSalesAndMarketingExpense
usd
CY2024Q4 us-gaap Disposal Group Including Discontinued Operation General And Administrative Expense
DisposalGroupIncludingDiscontinuedOperationGeneralAndAdministrativeExpense
usd
us-gaap Disposal Group Including Discontinued Operation General And Administrative Expense
DisposalGroupIncludingDiscontinuedOperationGeneralAndAdministrativeExpense
usd
CY2024Q4 us-gaap Disposal Group Including Discontinued Operation Operating Expense
DisposalGroupIncludingDiscontinuedOperationOperatingExpense
usd
us-gaap Disposal Group Including Discontinued Operation Operating Expense
DisposalGroupIncludingDiscontinuedOperationOperatingExpense
usd
CY2024Q4 us-gaap Disposal Group Including Discontinued Operation Operating Income Loss
DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss
usd
us-gaap Disposal Group Including Discontinued Operation Operating Income Loss
DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss
usd
CY2024Q4 us-gaap Disposal Group Including Discontinued Operation Interest Expense
DisposalGroupIncludingDiscontinuedOperationInterestExpense
usd
CY2023Q4 us-gaap Disposal Group Including Discontinued Operation Interest Expense
DisposalGroupIncludingDiscontinuedOperationInterestExpense
usd
us-gaap Disposal Group Including Discontinued Operation Interest Expense
DisposalGroupIncludingDiscontinuedOperationInterestExpense
usd
CY2024Q4 us-gaap Disposal Group Including Discontinued Operation Other Income
DisposalGroupIncludingDiscontinuedOperationOtherIncome
usd
us-gaap Disposal Group Including Discontinued Operation Other Income
DisposalGroupIncludingDiscontinuedOperationOtherIncome
usd
CY2024Q4 RCAT Disposal Group Including Discontinued Operation Other Income Expense
DisposalGroupIncludingDiscontinuedOperationOtherIncomeExpense
usd
RCAT Disposal Group Including Discontinued Operation Other Income Expense
DisposalGroupIncludingDiscontinuedOperationOtherIncomeExpense
usd
CY2024Q4 us-gaap Income Loss From Discontinued Operations Net Of Tax
IncomeLossFromDiscontinuedOperationsNetOfTax
usd
us-gaap Income Loss From Discontinued Operations Net Of Tax
IncomeLossFromDiscontinuedOperationsNetOfTax
usd
CY2024Q4 us-gaap Grants Receivable Current
GrantsReceivableCurrent
usd
CY2024Q4 RCAT Outstanding Principal Payments Due Long Term
OutstandingPrincipalPaymentsDueLongTerm
usd
dei Document Type
DocumentType
10-Q
dei Document Period End Date
DocumentPeriodEndDate
2024-10-31
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-40202
dei Entity Registrant Name
EntityRegistrantName
Red Cat Holdings, Inc.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
NV
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
88-0490034
dei Entity Address Address Line1
EntityAddressAddressLine1
15 Ave. Munoz Rivera
dei Entity Address Address Line2
EntityAddressAddressLine2
Ste 2200
dei Entity Address City Or Town
EntityAddressCityOrTown
San Juan
dei Entity Address Country
EntityAddressCountry
PR
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
00901
dei City Area Code
CityAreaCode
(833)
dei Local Phone Number
LocalPhoneNumber
373-3228
dei Security12b Title
Security12bTitle
Common stock, par value $0.001
dei Trading Symbol
TradingSymbol
RCAT
dei Security Exchange Name
SecurityExchangeName
NASDAQ
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2024Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
80160782 shares
CY2024Q4 us-gaap Cash
Cash
4611092 usd
CY2024Q2 us-gaap Cash
Cash
6067169 usd
CY2024Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
1121398 usd
CY2024Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
4361090 usd
CY2024Q4 us-gaap Inventory Net
InventoryNet
12165260 usd
CY2024Q2 us-gaap Inventory Net
InventoryNet
8007237 usd
CY2024Q4 us-gaap Other Assets Current
OtherAssetsCurrent
3015413 usd
CY2024Q2 us-gaap Other Assets Current
OtherAssetsCurrent
3962053 usd
CY2024Q4 us-gaap Assets Current
AssetsCurrent
20913163 usd
CY2024Q2 us-gaap Assets Current
AssetsCurrent
22397549 usd
CY2024Q4 us-gaap Goodwill
Goodwill
22964065 usd
CY2024Q2 us-gaap Goodwill
Goodwill
9088550 usd
CY2024Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
3439731 usd
CY2024Q2 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
3794389 usd
CY2024Q2 us-gaap Equity Method Investments
EquityMethodInvestments
5142500 usd
CY2024Q2 us-gaap Long Term Accounts Notes And Loans Receivable Net Noncurrent
LongTermAccountsNotesAndLoansReceivableNetNoncurrent
4000000 usd
CY2024Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1972859 usd
CY2024Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
2340684 usd
CY2024Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
309823 usd
CY2024Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
293126 usd
CY2024Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
1492747 usd
CY2024Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
1480814 usd
CY2024Q4 us-gaap Assets Noncurrent
AssetsNoncurrent
30179225 usd
CY2024Q2 us-gaap Assets Noncurrent
AssetsNoncurrent
26140063 usd
CY2024Q4 us-gaap Assets
Assets
51092388 usd
CY2024Q2 us-gaap Assets
Assets
48537612 usd
CY2024Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
1591488 usd
CY2024Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
1580422 usd
CY2024Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
1431908 usd
CY2024Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
1069561 usd
CY2024Q4 us-gaap Short Term Borrowings
ShortTermBorrowings
356964 usd
CY2024Q2 us-gaap Short Term Borrowings
ShortTermBorrowings
751570 usd
CY2024Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
221380 usd
CY2024Q2 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
53939 usd
CY2024Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
337628 usd
CY2024Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
195638 usd
CY2024Q4 us-gaap Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
3733338 usd
CY2024Q4 us-gaap Asset Acquisition Contingent Consideration Liability Current
AssetAcquisitionContingentConsiderationLiabilityCurrent
7000000 usd
CY2024Q4 us-gaap Liabilities Current
LiabilitiesCurrent
14672706 usd
CY2024Q2 us-gaap Liabilities Current
LiabilitiesCurrent
3651130 usd
CY2024Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
1213688 usd
CY2024Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
1321952 usd
CY2024Q4 us-gaap Convertible Long Term Notes Payable
ConvertibleLongTermNotesPayable
8177969 usd
CY2024Q4 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
9391657 usd
CY2024Q2 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
1321952 usd
CY2024Q4 us-gaap Liabilities
Liabilities
24064363 usd
CY2024Q2 us-gaap Liabilities
Liabilities
4973082 usd
CY2024Q4 RCAT Preferred Stock Value Series B
PreferredStockValueSeriesB
47 usd
CY2024Q2 RCAT Preferred Stock Value Series B
PreferredStockValueSeriesB
47 usd
CY2024Q4 us-gaap Common Stock Value
CommonStockValue
78025 usd
CY2024Q2 us-gaap Common Stock Value
CommonStockValue
74289 usd
CY2024Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
133831679 usd
CY2024Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
124616305 usd
CY2024Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-106881726 usd
CY2024Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-81130732 usd
CY2024Q4 us-gaap Stockholders Equity
StockholdersEquity
27028025 usd
CY2024Q2 us-gaap Stockholders Equity
StockholdersEquity
43564530 usd
CY2024Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
51092388 usd
CY2024Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
48537612 usd
CY2024Q4 us-gaap Revenues
Revenues
1534727 usd
CY2023Q4 us-gaap Revenues
Revenues
3930868 usd
us-gaap Revenues
Revenues
4311262 usd
us-gaap Revenues
Revenues
5678997 usd
CY2024Q4 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
1558202 usd
CY2023Q4 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
2730286 usd
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
4818128 usd
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
4303750 usd
CY2024Q4 us-gaap Gross Profit
GrossProfit
-23475 usd
CY2023Q4 us-gaap Gross Profit
GrossProfit
1200582 usd
us-gaap Gross Profit
GrossProfit
-506866 usd
us-gaap Gross Profit
GrossProfit
1375247 usd
CY2024Q4 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
2231470 usd
CY2023Q4 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
2222137 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
3857910 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
3575688 usd
CY2024Q4 us-gaap Marketing And Advertising Expense
MarketingAndAdvertisingExpense
2343779 usd
CY2023Q4 us-gaap Marketing And Advertising Expense
MarketingAndAdvertisingExpense
1032645 usd
us-gaap Marketing And Advertising Expense
MarketingAndAdvertisingExpense
4385290 usd
us-gaap Marketing And Advertising Expense
MarketingAndAdvertisingExpense
2321405 usd
CY2024Q4 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
4517695 usd
CY2023Q4 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
2838080 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
8000790 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
5701838 usd
us-gaap Impairment Of Intangible Assets Excluding Goodwill
ImpairmentOfIntangibleAssetsExcludingGoodwill
93050 usd
CY2024Q4 us-gaap Operating Expenses
OperatingExpenses
9092944 usd
CY2023Q4 us-gaap Operating Expenses
OperatingExpenses
6092862 usd
us-gaap Operating Expenses
OperatingExpenses
16337040 usd
us-gaap Operating Expenses
OperatingExpenses
11598931 usd
CY2024Q4 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
-9116419 usd
CY2023Q4 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
-4892280 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
-16843906 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
-10223684 usd
CY2024Q4 RCAT Convertible Notes Payable Fair Value Adjustment
ConvertibleNotesPayableFairValueAdjustment
4230307 usd
RCAT Convertible Notes Payable Fair Value Adjustment
ConvertibleNotesPayableFairValueAdjustment
4230307 usd
us-gaap Equity Method Investment Realized Gain Loss On Disposal
EquityMethodInvestmentRealizedGainLossOnDisposal
-4008357 usd
us-gaap Gain Loss On Sale Of Stock In Subsidiary Or Equity Method Investee
GainLossOnSaleOfStockInSubsidiaryOrEquityMethodInvestee
-734143 usd
CY2023Q4 us-gaap Investment Income Net
InvestmentIncomeNet
-333867 usd
us-gaap Investment Income Net
InvestmentIncomeNet
-573357 usd
CY2024Q4 us-gaap Interest Expense
InterestExpense
-14634 usd
CY2023Q4 us-gaap Interest Expense
InterestExpense
19696 usd
us-gaap Interest Expense
InterestExpense
-39188 usd
us-gaap Interest Expense
InterestExpense
41553 usd
CY2024Q4 us-gaap Other Nonrecurring Income Expense
OtherNonrecurringIncomeExpense
2526 usd
CY2023Q4 us-gaap Other Nonrecurring Income Expense
OtherNonrecurringIncomeExpense
-1544 usd
us-gaap Other Nonrecurring Income Expense
OtherNonrecurringIncomeExpense
-26531 usd
CY2024Q4 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-4218199 usd
CY2023Q4 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-352019 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-8907088 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-614910 usd
CY2024Q4 us-gaap Operating Income Loss
OperatingIncomeLoss
-13334618 usd
CY2023Q4 us-gaap Operating Income Loss
OperatingIncomeLoss
-5244299 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-25750994 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-10838594 usd
CY2023Q4 us-gaap Income Loss From Discontinued Operations Net Of Tax
IncomeLossFromDiscontinuedOperationsNetOfTax
-599511 usd
us-gaap Income Loss From Discontinued Operations Net Of Tax
IncomeLossFromDiscontinuedOperationsNetOfTax
-842084 usd
CY2024Q4 us-gaap Net Income Loss
NetIncomeLoss
-13334618 usd
CY2023Q4 us-gaap Net Income Loss
NetIncomeLoss
-5843810 usd
us-gaap Net Income Loss
NetIncomeLoss
-25750994 usd
us-gaap Net Income Loss
NetIncomeLoss
-11680678 usd
CY2023Q4 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Before Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent
1376 usd
us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Before Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent
-4621 usd
us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Before Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent
3022 usd
CY2023Q4 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
363663 usd
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
653052 usd
CY2024Q4 us-gaap Other Comprehensive Income Loss Before Tax
OtherComprehensiveIncomeLossBeforeTax
-13334618 usd
CY2023Q4 us-gaap Other Comprehensive Income Loss Before Tax
OtherComprehensiveIncomeLossBeforeTax
-5478771 usd
us-gaap Other Comprehensive Income Loss Before Tax
OtherComprehensiveIncomeLossBeforeTax
-25755615 usd
us-gaap Other Comprehensive Income Loss Before Tax
OtherComprehensiveIncomeLossBeforeTax
-11024604 usd
CY2024Q4 RCAT Earnings Per Share Basic And Diluted Continuing Operations Rcat
EarningsPerShareBasicAndDilutedContinuingOperationsRCAT
-0.18
CY2023Q4 RCAT Earnings Per Share Basic And Diluted Continuing Operations Rcat
EarningsPerShareBasicAndDilutedContinuingOperationsRCAT
-0.10
RCAT Earnings Per Share Basic And Diluted Continuing Operations Rcat
EarningsPerShareBasicAndDilutedContinuingOperationsRCAT
-0.34
RCAT Earnings Per Share Basic And Diluted Continuing Operations Rcat
EarningsPerShareBasicAndDilutedContinuingOperationsRCAT
-0.19
CY2023Q4 RCAT Earnings Per Share Basic And Diluted Discontinued Operations Rcat
EarningsPerShareBasicAndDilutedDiscontinuedOperationsRCAT
-0.01
RCAT Earnings Per Share Basic And Diluted Discontinued Operations Rcat
EarningsPerShareBasicAndDilutedDiscontinuedOperationsRCAT
-0.02
CY2024Q4 RCAT Weighted Average Number Of Share Outstanding Basic And Diluted Rcat
WeightedAverageNumberOfShareOutstandingBasicAndDilutedRCAT
76184777 shares
CY2023Q4 RCAT Weighted Average Number Of Share Outstanding Basic And Diluted Rcat
WeightedAverageNumberOfShareOutstandingBasicAndDilutedRCAT
55606336 shares
RCAT Weighted Average Number Of Share Outstanding Basic And Diluted Rcat
WeightedAverageNumberOfShareOutstandingBasicAndDilutedRCAT
75342629 shares
RCAT Weighted Average Number Of Share Outstanding Basic And Diluted Rcat
WeightedAverageNumberOfShareOutstandingBasicAndDilutedRCAT
55270838 shares
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
54767941 usd
CY2023Q3 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
911606 usd
CY2023Q3 us-gaap Restricted Stock Value Shares Issued Net Of Tax Withholdings
RestrictedStockValueSharesIssuedNetOfTaxWithholdings
-8520 usd
CY2023Q3 us-gaap Marketable Securities Unrealized Gain Loss
MarketableSecuritiesUnrealizedGainLoss
289389 usd
CY2023Q3 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
1646 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-5836868 usd
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
50125194 usd
CY2023Q4 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
1196325 usd
CY2023Q4 us-gaap Restricted Stock Value Shares Issued Net Of Tax Withholdings
RestrictedStockValueSharesIssuedNetOfTaxWithholdings
-7771 usd
CY2023Q4 RCAT Issuance Of Common Stock Atm Facility Net Amount
IssuanceOfCommonStockATMFacilityNetAmount
9212 usd
CY2023Q4 us-gaap Marketable Securities Unrealized Gain Loss
MarketableSecuritiesUnrealizedGainLoss
363663 usd
CY2023Q4 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
1376 usd
CY2023Q4 us-gaap Net Income Loss
NetIncomeLoss
-5843810 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
45844189 usd
CY2024Q2 us-gaap Stockholders Equity
StockholdersEquity
43564530 usd
CY2024Q3 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
1446038 usd
CY2024Q3 us-gaap Restricted Stock Value Shares Issued Net Of Tax Withholdings
RestrictedStockValueSharesIssuedNetOfTaxWithholdings
-134037 usd
CY2024Q3 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-4621 usd
CY2024Q3 us-gaap Net Income Loss
NetIncomeLoss
-12416376 usd
CY2024Q3 us-gaap Stockholders Equity
StockholdersEquity
32455534 usd
CY2024Q4 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
1304037 usd
CY2024Q4 us-gaap Restricted Stock Value Shares Issued Net Of Tax Withholdings
RestrictedStockValueSharesIssuedNetOfTaxWithholdings
-411894 usd
CY2024Q4 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
14966 usd
CY2024Q4 us-gaap Stock Issued During Period Value Acquisitions
StockIssuedDuringPeriodValueAcquisitions
7000000 usd
CY2024Q4 us-gaap Net Income Loss
NetIncomeLoss
-13334618 usd
CY2024Q4 us-gaap Stockholders Equity
StockholdersEquity
27028025 usd
us-gaap Net Income Loss
NetIncomeLoss
-25750994 usd
us-gaap Net Income Loss
NetIncomeLoss
-11680678 usd
RCAT Income Loss From Discontinued Operations
IncomeLossFromDiscontinuedOperations
842084 usd
us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
-25750994 usd
us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
-10838594 usd
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1
815632 usd
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1
1606305 usd
RCAT Sharebased Compensation Arrangement By Sharebased Payment Award Restricte Units Vested In Period Fair Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardRestricteUnitsVestedInPeriodFairValue1
1934443 usd
RCAT Sharebased Compensation Arrangement By Sharebased Payment Award Restricte Units Vested In Period Fair Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardRestricteUnitsVestedInPeriodFairValue1
501626 usd
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
354658 usd
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
434735 usd
us-gaap Marketable Securities Gain Loss
MarketableSecuritiesGainLoss
646300 usd
us-gaap Depreciation
Depreciation
491618 usd
us-gaap Depreciation
Depreciation
222431 usd
us-gaap Equity Method Investment Realized Gain Loss On Disposal
EquityMethodInvestmentRealizedGainLossOnDisposal
-4008357 usd
us-gaap Gain Loss On Sale Of Stock In Subsidiary Or Equity Method Investee
GainLossOnSaleOfStockInSubsidiaryOrEquityMethodInvestee
-734143 usd
us-gaap Impairment Of Intangible Assets Excluding Goodwill
ImpairmentOfIntangibleAssetsExcludingGoodwill
93050 usd
RCAT Convertible Notes Payable Fair Value Adjustment
ConvertibleNotesPayableFairValueAdjustment
4230307 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
3394692 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-2269192 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-3860393 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-335125 usd
us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
999423 usd
us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
-1576157 usd
RCAT Increase Decrease In Operating Lease Right Of Use Assets And Liabilities
IncreaseDecreaseInOperatingLeaseRightOfUseAssetsAndLiabilities
-7913 usd
RCAT Increase Decrease In Operating Lease Right Of Use Assets And Liabilities
IncreaseDecreaseInOperatingLeaseRightOfUseAssetsAndLiabilities
-1115 usd
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-29035 usd
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-94181 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
9887 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
225801 usd
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
94412 usd
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
236807 usd
us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-12487713 usd
us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-11240359 usd
us-gaap Payments To Acquire Productive Assets
PaymentsToAcquireProductiveAssets
123793 usd
us-gaap Payments To Acquire Productive Assets
PaymentsToAcquireProductiveAssets
139860 usd
us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
10205501 usd
us-gaap Proceeds From Sale Of Equity Method Investments
ProceedsFromSaleOfEquityMethodInvestments
4400000 usd
us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
4276207 usd
us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
10065641 usd
us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
7681000 usd
us-gaap Repayments Of Debt
RepaymentsOfDebt
394606 usd
us-gaap Repayments Of Debt
RepaymentsOfDebt
279126 usd
RCAT Payments Of Taxes Related To Equity Transactions
PaymentsOfTaxesRelatedToEquityTransactions
530965 usd
RCAT Payments Of Taxes Related To Equity Transactions
PaymentsOfTaxesRelatedToEquityTransactions
16292 usd
us-gaap Proceeds From Issuance Or Sale Of Equity
ProceedsFromIssuanceOrSaleOfEquity
9212 usd
us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
6755429 usd
us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
-286206 usd
us-gaap Cash Provided By Used In Operating Activities Discontinued Operations
CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations
-550120 usd
us-gaap Cash Provided By Used In Financing Activities Discontinued Operations
CashProvidedByUsedInFinancingActivitiesDiscontinuedOperations
166026 usd
us-gaap Net Cash Provided By Used In Discontinued Operations
NetCashProvidedByUsedInDiscontinuedOperations
-384094 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-1456077 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-1845018 usd
CY2024Q2 us-gaap Cash And Cash Equivalents At Carrying Value Including Discontinued Operations
CashAndCashEquivalentsAtCarryingValueIncludingDiscontinuedOperations
6067169 usd
CY2023Q2 us-gaap Cash And Cash Equivalents At Carrying Value Including Discontinued Operations
CashAndCashEquivalentsAtCarryingValueIncludingDiscontinuedOperations
3260305 usd
CY2024Q4 us-gaap Cash And Cash Equivalents At Carrying Value Including Discontinued Operations
CashAndCashEquivalentsAtCarryingValueIncludingDiscontinuedOperations
4611092 usd
CY2023Q4 us-gaap Cash And Cash Equivalents At Carrying Value Including Discontinued Operations
CashAndCashEquivalentsAtCarryingValueIncludingDiscontinuedOperations
1415287 usd
CY2023Q4 us-gaap Disposal Group Including Discontinued Operation Cash
DisposalGroupIncludingDiscontinuedOperationCash
6310 usd
CY2024Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
4611092 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1408977 usd
us-gaap Interest Paid Net
InterestPaidNet
14564 usd
us-gaap Interest Paid Net
InterestPaidNet
42031 usd
us-gaap Stock Issued During Period Value Acquisitions
StockIssuedDuringPeriodValueAcquisitions
7000000 usd
us-gaap Business Combination Consideration Transferred1
BusinessCombinationConsiderationTransferred1
7000000 usd
us-gaap Noncash Or Part Noncash Acquisition Net Nonmonetary Assets Acquired Liabilities Assumed1
NoncashOrPartNoncashAcquisitionNetNonmonetaryAssetsAcquiredLiabilitiesAssumed1
31435 usd
us-gaap Other Comprehensive Income Availableforsale Securities Adjustment Before Tax Portion Attributable To Parent
OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentBeforeTaxPortionAttributableToParent
653052 usd
RCAT Conversion Of Preferred Stock Into Common Stock
ConversionOfPreferredStockIntoCommonStock
9820 usd
us-gaap Use Of Estimates
UseOfEstimates
<p id="xdx_84B_eus-gaap--UseOfEstimates_zXnEvguIaaU6" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><span id="xdx_868_zr0GepZuKBH5">Use of Estimates</span></b> –<span style="background-color: white"> The preparation of financial statements in accordance with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities at the date of the financial statements, and the reported amounts of revenue and expenses during the reporting period. Actual results could differ from those estimates. Significant estimates reflected in these financial statements include those used to (i) complete purchase price accounting for acquisitions, (ii) the evaluation of long-term assets, including goodwill, for impairment, (iii) the evaluation of other-than-temporary-impairment of equity method investments, and (iv) valuations of convertible notes payable.</span></p>
us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p id="xdx_846_eus-gaap--ConcentrationRiskCreditRisk_zciqPlpySOH1" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><span id="xdx_868_zbtI5ML8pDvf">Concentration of Credit Risk</span> </b>– Financial instruments, which potentially subject the Company to concentrations of credit risk, include trade receivables. In the normal course of business, the Company provides credit terms to its customers. Accordingly, the Company performs ongoing credit evaluations of its customers, generally does not require collateral and considers the credit risk profile of the customer from which the receivable is due in further evaluating collection risk. Customers that accounted for 10% or greater of accounts receivable, net as of October 31, 2024 and April 30, 2024 were as follows:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <table cellpadding="0" cellspacing="0" id="xdx_894_eus-gaap--SchedulesOfConcentrationOfRiskByRiskFactorTextBlock_zQaKUgLgYhkf" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 70%" summary="xdx: Disclosure - Customer concentration risk (Details)"> <tr style="vertical-align: bottom"> <td style="font-size: 12pt"><b> </b></td><td style="padding-bottom: 1pt"><b> </b></td> <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><b>October 31, 2024</b></td><td style="padding-bottom: 1pt"><b> </b></td> <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><b>April 30, 2024</b></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; width: 42%">Customer A</td><td style="width: 1%"> </td> <td style="text-align: left; width: 1%"> </td><td id="xdx_98C_eus-gaap--ConcentrationRiskPercentage1_dp_c20240501__20241031__us-gaap--ConcentrationRiskByTypeAxis__custom--CustomerConcentrationRisk1Member_zzQRZ5AtTVve" style="text-align: right; width: 25%">38</td><td style="text-align: left; width: 1%">%</td> <td style="width: 3%"> </td> <td style="text-align: left; width: 1%"> </td><td style="text-align: right; width: 25%">*</td><td style="text-align: left; width: 1%"></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Customer B</td><td> </td> <td style="text-align: left"> </td><td id="xdx_983_eus-gaap--ConcentrationRiskPercentage1_dp_c20240501__20241031__us-gaap--ConcentrationRiskByTypeAxis__custom--CustomerConcentrationRisk2Member_zeAehLlxS1u2" style="text-align: right">25</td><td style="text-align: left">%</td> <td> </td> <td style="text-align: left"> </td><td style="text-align: right">*</td><td style="text-align: left"></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Customer C</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">*</td><td style="text-align: left"></td> <td> </td> <td style="text-align: left"> </td><td id="xdx_982_eus-gaap--ConcentrationRiskPercentage1_dp_c20230501__20240430__us-gaap--ConcentrationRiskByTypeAxis__custom--CustomerConcentrationRisk1Member_zkScLhNOBd2e" style="text-align: right">53</td><td style="text-align: left">%</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Customer D</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">*</td><td style="text-align: left"></td> <td> </td> <td style="text-align: left"> </td><td id="xdx_98D_eus-gaap--ConcentrationRiskPercentage1_dp_c20230501__20240430__us-gaap--ConcentrationRiskByTypeAxis__custom--CustomerConcentrationRisk2Member_zccHnIrdNlVk" style="text-align: right">24</td><td style="text-align: left">%</td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"></p> <p id="xdx_8A5_zRUNRBn0u7Bj" style="font: 10pt Times New Roman, Times, Serif; margin: 0">   </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">* Accounts Receivable was less than 10%</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-size: 10pt">During the six months ended October 31, 2024, two customers accounted for equal to or greater than 10% of total revenue, totaling 21% and 19%, respectively. During the six months ended October 31, 2023, three customers accounted for equal to or greater than 10% of total revenue, totaling 13%, 12% and 10%, respectively. The Company does not believe the loss of one or more of these customers would be significant to operations.</span><span style="font-size: 8pt"></span></p>
CY2024 us-gaap Asset Impairment Charges
AssetImpairmentCharges
11353875 usd
CY2024Q4 us-gaap Financial Instruments Owned At Fair Value
FinancialInstrumentsOwnedAtFairValue
11911307 usd
CY2024Q4 RCAT Fair Value Assumptions Convertible Notes Payable Issuance Date
FairValueAssumptionsConvertibleNotesPayableIssuanceDate
2024-10-01
CY2024Q4 RCAT Fair Value Assumptions Convertible Notes Payable Maturity Date
FairValueAssumptionsConvertibleNotesPayableMaturityDate
2026-10-01
CY2024Q4 us-gaap Share Price
SharePrice
3.06
CY2024Q4 RCAT Fair Value Assumptions Convertible Notes Payable Expected Volatility
FairValueAssumptionsConvertibleNotesPayableExpectedVolatility
0.928 pure
CY2024Q4 RCAT Fair Value Assumptions Convertible Notes Payable Risk Free Interest Rate
FairValueAssumptionsConvertibleNotesPayableRiskFreeInterestRate
0.0521 pure
RCAT Fair Value Level3 Convertible Notes Payable Additions
FairValueLevel3ConvertibleNotesPayableAdditions
7681000 usd
RCAT Fair Value Level3 Convertible Notes Payable Adjustments
FairValueLevel3ConvertibleNotesPayableAdjustments
4230307 usd
CY2024Q4 RCAT Fair Value Level3 Convertible Notes Payable Balance
FairValueLevel3ConvertibleNotesPayableBalance
11911307 usd
CY2024Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
221380 usd
CY2024Q2 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
53939 usd
CY2024Q4 us-gaap Contract With Customer Asset Gross Current
ContractWithCustomerAssetGrossCurrent
0 usd
CY2024Q2 us-gaap Contract With Customer Asset Gross Current
ContractWithCustomerAssetGrossCurrent
1477859 usd
CY2023Q4 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
529437 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
886440 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
840318 usd
CY2024Q4 us-gaap Revenue Not From Contract With Customer
RevenueNotFromContractWithCustomer
1534727 usd
CY2023Q4 us-gaap Revenue Not From Contract With Customer
RevenueNotFromContractWithCustomer
3401431 usd
us-gaap Revenue Not From Contract With Customer
RevenueNotFromContractWithCustomer
3424822 usd
us-gaap Revenue Not From Contract With Customer
RevenueNotFromContractWithCustomer
4838679 usd
CY2024Q4 us-gaap Revenues
Revenues
1534727 usd
CY2023Q4 us-gaap Revenues
Revenues
3930868 usd
us-gaap Revenues
Revenues
4311262 usd
us-gaap Revenues
Revenues
5678997 usd
us-gaap Guarantees Indemnifications And Warranties Policies
GuaranteesIndemnificationsAndWarrantiesPolicies
<p id="xdx_84A_eus-gaap--GuaranteesIndemnificationsAndWarrantiesPolicies_zavr3n4hpGac" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><span id="xdx_864_z9uuUbYokKq3">Product Warranty</span> - </b>The Company accrues an estimate of its exposure to warranty claims based upon both current and historical product sales data and warranty costs incurred. Product warranty reserves are recorded in current liabilities under accrued expenses. Warranty liability was approximately $<span id="xdx_903_eus-gaap--StandardProductWarrantyAccrualCurrent_iI_c20241031_zlR6jx75dorh">587,000 </span> and $<span id="xdx_90B_eus-gaap--StandardProductWarrantyAccrualCurrent_iI_c20240430_zwsuYmVXQiCa">372,000 </span> as of October 31, 2024 and April 30, 2024 respectively.</p>
CY2024Q4 us-gaap Standard Product Warranty Accrual Current
StandardProductWarrantyAccrualCurrent
587000 usd
CY2024Q2 us-gaap Standard Product Warranty Accrual Current
StandardProductWarrantyAccrualCurrent
372000 usd
RCAT Difference Between Comprehensive Loss And Net Loss
DifferenceBetweenComprehensiveLossAndNetLoss
4621 usd
RCAT Difference Between Comprehensive Loss And Net Loss
DifferenceBetweenComprehensiveLossAndNetLoss
656074 usd
us-gaap Debt Securities Available For Sale Unrealized Gain Loss
DebtSecuritiesAvailableForSaleUnrealizedGainLoss
0 usd
us-gaap Debt Securities Available For Sale Unrealized Gain Loss
DebtSecuritiesAvailableForSaleUnrealizedGainLoss
653052 usd
us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Before Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent
3022 usd
RCAT Antidilutive Securities Excluded From Computation Of Earnings Per Share Series B Preferred Stock Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareSeriesBPreferredStockAmount
3896 shares
RCAT Antidilutive Securities Excluded From Computation Of Earnings Per Share Series B Preferred Stock Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareSeriesBPreferredStockAmount
3896 shares
RCAT Antidilutive Securities Excluded From Computation Of Earnings Per Share Stock Options Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareStockOptionsAmount
7896903 shares
RCAT Antidilutive Securities Excluded From Computation Of Earnings Per Share Stock Options Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareStockOptionsAmount
6861517 shares
RCAT Antidilutive Securities Excluded From Computation Of Earnings Per Share Warrants Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareWarrantsAmount
2292207 shares
RCAT Antidilutive Securities Excluded From Computation Of Earnings Per Share Warrants Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareWarrantsAmount
1539999 shares
RCAT Antidilutive Securities Excluded From Computation Of Earnings Per Share Restricted Stock Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareRestrictedStockAmount
1758313 shares
RCAT Antidilutive Securities Excluded From Computation Of Earnings Per Share Restricted Stock Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareRestrictedStockAmount
779850 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
11951319 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
9185262 shares
CY2024Q4 us-gaap Capital
Capital
6240000 usd
CY2024Q3 RCAT Firm Commitment Underwritten Public Offering Net Proceeds
FirmCommitmentUnderwrittenPublicOfferingNetProceeds
8000000 usd
CY2024Q4 RCAT Firm Commitment Underwritten Public Offering Net Proceeds
FirmCommitmentUnderwrittenPublicOfferingNetProceeds
6000000 usd
CY2024 us-gaap Noncash Or Part Noncash Divestiture Amount Of Consideration Received1
NoncashOrPartNoncashDivestitureAmountOfConsiderationReceived1
20 usd
CY2024 RCAT Noncash Or Part Noncash Divestiture Cash Consideration Received1
NoncashOrPartNoncashDivestitureCashConsiderationReceived1
1000000 usd
CY2024 RCAT Noncash Or Part Noncash Divestiture Promissory Note Consideration Received1
NoncashOrPartNoncashDivestiturePromissoryNoteConsiderationReceived1
2000000 usd
CY2024 RCAT Noncash Or Part Noncash Divestiture Securities Consideration Received1
NoncashOrPartNoncashDivestitureSecuritiesConsiderationReceived1
17000000 usd
RCAT Noncash Or Part Noncash Divestiture Securities Consideration Received1
NoncashOrPartNoncashDivestitureSecuritiesConsiderationReceived1
17000000 usd
RCAT Noncash Or Part Noncash Divestiture Securities Consideration Received Shares
NoncashOrPartNoncashDivestitureSecuritiesConsiderationReceivedShares
4250000 shares
CY2024Q1 RCAT Working Capital At Closing Of Disposal Group
WorkingCapitalAtClosingOfDisposalGroup
2000000 usd
CY2023Q4 us-gaap Disposal Group Including Discontinued Operation Revenue
DisposalGroupIncludingDiscontinuedOperationRevenue
1056932 usd
us-gaap Disposal Group Including Discontinued Operation Revenue
DisposalGroupIncludingDiscontinuedOperationRevenue
2926151 usd
CY2023Q4 us-gaap Disposal Group Including Discontinued Operation Costs Of Goods Sold
DisposalGroupIncludingDiscontinuedOperationCostsOfGoodsSold
1154200 usd
us-gaap Disposal Group Including Discontinued Operation Costs Of Goods Sold
DisposalGroupIncludingDiscontinuedOperationCostsOfGoodsSold
2539316 usd
CY2023Q4 us-gaap Disposal Group Including Discontinued Operation Gross Profit Loss
DisposalGroupIncludingDiscontinuedOperationGrossProfitLoss
-97268 usd
us-gaap Disposal Group Including Discontinued Operation Gross Profit Loss
DisposalGroupIncludingDiscontinuedOperationGrossProfitLoss
386835 usd
CY2023Q4 RCAT Disposal Group Including Discontinued Operation Research And Development Expense
DisposalGroupIncludingDiscontinuedOperationResearchAndDevelopmentExpense
31054 usd
RCAT Disposal Group Including Discontinued Operation Research And Development Expense
DisposalGroupIncludingDiscontinuedOperationResearchAndDevelopmentExpense
77303 usd
CY2023Q4 RCAT Disposal Group Including Discontinued Operation Sales And Marketing Expense
DisposalGroupIncludingDiscontinuedOperationSalesAndMarketingExpense
287413 usd
RCAT Disposal Group Including Discontinued Operation Sales And Marketing Expense
DisposalGroupIncludingDiscontinuedOperationSalesAndMarketingExpense
691517 usd
CY2023Q4 us-gaap Disposal Group Including Discontinued Operation General And Administrative Expense
DisposalGroupIncludingDiscontinuedOperationGeneralAndAdministrativeExpense
183807 usd
us-gaap Disposal Group Including Discontinued Operation General And Administrative Expense
DisposalGroupIncludingDiscontinuedOperationGeneralAndAdministrativeExpense
437393 usd
CY2023Q4 us-gaap Disposal Group Including Discontinued Operation Operating Expense
DisposalGroupIncludingDiscontinuedOperationOperatingExpense
502274 usd
us-gaap Disposal Group Including Discontinued Operation Operating Expense
DisposalGroupIncludingDiscontinuedOperationOperatingExpense
1206213 usd
CY2023Q4 us-gaap Disposal Group Including Discontinued Operation Operating Income Loss
DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss
-599542 usd
us-gaap Disposal Group Including Discontinued Operation Operating Income Loss
DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss
-819378 usd
us-gaap Disposal Group Including Discontinued Operation Interest Expense
DisposalGroupIncludingDiscontinuedOperationInterestExpense
22856 usd
CY2023Q4 us-gaap Disposal Group Including Discontinued Operation Other Income
DisposalGroupIncludingDiscontinuedOperationOtherIncome
31 usd
us-gaap Disposal Group Including Discontinued Operation Other Income
DisposalGroupIncludingDiscontinuedOperationOtherIncome
150 usd
CY2023Q4 RCAT Disposal Group Including Discontinued Operation Other Income Expense
DisposalGroupIncludingDiscontinuedOperationOtherIncomeExpense
-31 usd
RCAT Disposal Group Including Discontinued Operation Other Income Expense
DisposalGroupIncludingDiscontinuedOperationOtherIncomeExpense
22706 usd
CY2023Q4 us-gaap Income Loss From Discontinued Operations Net Of Tax
IncomeLossFromDiscontinuedOperationsNetOfTax
-599511 usd
us-gaap Income Loss From Discontinued Operations Net Of Tax
IncomeLossFromDiscontinuedOperationsNetOfTax
-842084 usd
CY2024Q4 us-gaap Inventory Raw Materials
InventoryRawMaterials
6110038 usd
CY2024Q2 us-gaap Inventory Raw Materials
InventoryRawMaterials
5750324 usd
CY2024Q4 us-gaap Inventory Work In Process
InventoryWorkInProcess
1214769 usd
CY2024Q2 us-gaap Inventory Work In Process
InventoryWorkInProcess
1289997 usd
CY2024Q4 us-gaap Inventory Finished Goods
InventoryFinishedGoods
4840453 usd
CY2024Q2 us-gaap Inventory Finished Goods
InventoryFinishedGoods
966916 usd
CY2024Q4 us-gaap Inventory Net
InventoryNet
12165260 usd
CY2024Q2 us-gaap Inventory Net
InventoryNet
8007237 usd
CY2024Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
2626343 usd
CY2024Q2 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
1206306 usd
CY2024Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
389070 usd
CY2024Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
602888 usd
CY2024Q4 us-gaap Contract With Customer Asset Gross Current
ContractWithCustomerAssetGrossCurrent
0 usd
CY2024Q2 us-gaap Contract With Customer Asset Gross Current
ContractWithCustomerAssetGrossCurrent
1477859 usd
CY2024Q2 us-gaap Grants Receivable Current
GrantsReceivableCurrent
675000 usd
CY2024Q4 us-gaap Other Assets Current
OtherAssetsCurrent
3015413 usd
CY2024Q2 us-gaap Other Assets Current
OtherAssetsCurrent
3962053 usd
RCAT Exchange Agreement Shares Exchanged
ExchangeAgreementSharesExchanged
4250000 shares
RCAT Exchange Agreement Shares Exchanged Par Value
ExchangeAgreementSharesExchangedParValue
0.001
RCAT Exchange Agreement Preferred Shares Received
ExchangeAgreementPreferredSharesReceived
4250 shares
RCAT Exchange Agreement Shares Preferred Stock Value Sold
ExchangeAgreementSharesPreferredStockValueSold
4408357 usd
RCAT Note Receivable Sold Pursuant To Exchange Agreement
NoteReceivableSoldPursuantToExchangeAgreement
4000000 usd
RCAT Proceeds From Purchase Agreement
ProceedsFromPurchaseAgreement
4400000 usd
CY2024 us-gaap Variable Interest Entity Ownership Percentage
VariableInterestEntityOwnershipPercentage
0.46 pure
CY2024Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
1633105 usd
CY2024Q2 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
1540888 usd
CY2024Q4 us-gaap Leasehold Improvements Gross
LeaseholdImprovementsGross
1556139 usd
CY2024Q2 us-gaap Leasehold Improvements Gross
LeaseholdImprovementsGross
1547976 usd
CY2024Q4 us-gaap Furniture And Fixtures Gross
FurnitureAndFixturesGross
186703 usd
CY2024Q2 us-gaap Furniture And Fixtures Gross
FurnitureAndFixturesGross
163290 usd
CY2024Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
1403088 usd
CY2024Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
911470 usd
CY2024Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1972859 usd
CY2024Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
2340684 usd
us-gaap Depreciation
Depreciation
491618 usd
us-gaap Depreciation
Depreciation
222431 usd
CY2024Q4 RCAT Safe Agreement Assets
SAFEAgreementAssets
250000 usd
CY2024Q2 RCAT Safe Agreement Assets
SAFEAgreementAssets
250000 usd
CY2024Q4 us-gaap Security Deposit
SecurityDeposit
43126 usd
CY2024Q2 us-gaap Security Deposit
SecurityDeposit
43126 usd
CY2024Q4 us-gaap Noncurrent Assets
NoncurrentAssets
293126 usd
CY2024Q2 us-gaap Noncurrent Assets
NoncurrentAssets
293126 usd
CY2022Q4 RCAT Payment For Safe Agreement
PaymentForSAFEAgreement
250000 usd
CY2022Q4 RCAT Payment For Safe Agreement
PaymentForSAFEAgreement
250000 usd
us-gaap Operating Lease Expense
OperatingLeaseExpense
262912 usd
us-gaap Operating Lease Expense
OperatingLeaseExpense
170505 usd
RCAT Operating Cash Paid To Settle Lease Liabilities
OperatingCashPaidToSettleLeaseLiabilities
215922 usd
CY2024Q4 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P2Y6M
CY2024Q4 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.12 pure
CY2024Q2 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
370537 usd
CY2024Q4 RCAT Outstanding Principal Payments Due Year One
OutstandingPrincipalPaymentsDueYearOne
356964 usd
CY2024Q4 RCAT Outstanding Principal Payments Due Total
OutstandingPrincipalPaymentsDueTotal
356964 usd
CY2024Q3 RCAT Proceeds Received From Convertible Notes Payable
ProceedsReceivedFromConvertibleNotesPayable
8000000 usd
CY2024Q3 RCAT Convertible Notes Payable Lind
ConvertibleNotesPayableLind
9600000 usd
CY2024Q3 RCAT Common Stock Purchase Warrant Lind
CommonStockPurchaseWarrantLind
750000 shares
CY2024Q3 RCAT Common Stock Purchase Warrant Purchase Price Per Share Lind
CommonStockPurchaseWarrantPurchasePricePerShareLind
6.50
CY2024Q3 RCAT Securities Purchase Agreement Lind Commitment Fee Expense
SecuritiesPurchaseAgreementLindCommitmentFeeExpense
280000 usd
CY2024Q4 RCAT Convertible Notes Payable Lind Monthly Installment Amount
ConvertibleNotesPayableLindMonthlyInstallmentAmount
533334 usd
CY2024Q4 RCAT Convertible Notes Payable Lind Monthly Installment Amount Optional Increase
ConvertibleNotesPayableLindMonthlyInstallmentAmountOptionalIncrease
1000000 usd
CY2024Q4 RCAT Convertible Notes Payable Lind Monthly Installment Amount Market Capitalization Minimum Requirement
ConvertibleNotesPayableLindMonthlyInstallmentAmountMarketCapitalizationMinimumRequirement
50000000 usd
CY2024Q4 RCAT Convertible Notes Payable Lind Repayment Share Price Minimum
ConvertibleNotesPayableLindRepaymentSharePriceMinimum
2.00
CY2024Q4 RCAT Convertible Notes Payable Lind Monthly Installment Amount Optional Increase2
ConvertibleNotesPayableLindMonthlyInstallmentAmountOptionalIncrease2
1300000 usd
CY2024Q4 RCAT Convertible Notes Payable Lind Repayment Share Price Floor Price
ConvertibleNotesPayableLindRepaymentSharePriceFloorPrice
0.75
CY2024Q4 RCAT Convertible Notes Payable Lind Conversion Price
ConvertibleNotesPayableLindConversionPrice
6.50
CY2024Q4 RCAT Convertible Notes Payable Lind Conversion Principal Amount Percentage
ConvertibleNotesPayableLindConversionPrincipalAmountPercentage
0.25 pure
CY2024Q4 RCAT Convertible Notes Payable Lind Repayment Share Price Minimum
ConvertibleNotesPayableLindRepaymentSharePriceMinimum
2.00
CY2024Q4 us-gaap Convertible Notes Payable
ConvertibleNotesPayable
11911307 usd
CY2024Q4 RCAT Convertible Notes Payable Lind Conversion Amount
ConvertibleNotesPayableLindConversionAmount
1300000 usd
CY2024Q4 RCAT Convertible Notes Payable Lind Conversion Shares
ConvertibleNotesPayableLindConversionShares
200000 shares
CY2024Q4 RCAT Convertible Notes Payable Lind Conversion Amount2
ConvertibleNotesPayableLindConversionAmount2
2600000 usd
CY2024Q4 RCAT Convertible Notes Payable Lind Conversion Amount3
ConvertibleNotesPayableLindConversionAmount3
3250000 usd
CY2024Q4 RCAT Convertible Notes Payable Lind Conversion Shares2
ConvertibleNotesPayableLindConversionShares2
400000 shares
CY2024Q4 RCAT Convertible Notes Payable Lind Conversion Shares3
ConvertibleNotesPayableLindConversionShares3
500000 shares
CY2024Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
500000000 shares
CY2023Q4 us-gaap Partners Capital Account Units Sold In Public Offering
PartnersCapitalAccountUnitsSoldInPublicOffering
16000000 shares
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2023Q4 RCAT Public Offering Price Per Share
PublicOfferingPricePerShare
0.50
CY2023Q4 RCAT Additional Shares Purchase Option Over Allotment Cover
AdditionalSharesPurchaseOptionOverAllotmentCover
2400000 shares
CY2023Q4 RCAT Firm Commitment Underwritten Public Offering Shares
FirmCommitmentUnderwrittenPublicOfferingShares
18400000 shares
CY2023Q4 RCAT Firm Commitment Underwritten Public Offering Gross Proceeds
FirmCommitmentUnderwrittenPublicOfferingGrossProceeds
9200000 usd
CY2023Q4 RCAT Firm Commitment Underwritten Public Offering Net Proceeds
FirmCommitmentUnderwrittenPublicOfferingNetProceeds
8400000 usd
CY2024Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2023Q2 RCAT Preferred Stock Convertible
PreferredStockConvertible
982000 shares
CY2023Q2 RCAT Preferred Stock Convertible Shares Issued
PreferredStockConvertibleSharesIssued
818334 shares
CY2022Q2 RCAT Warrants Issued Exercise Price
WarrantsIssuedExercisePrice
1.50
CY2020Q4 RCAT Number Of Warrants Upon Issuance
NumberOfWarrantsUponIssuance
399998 shares
CY2020Q4 RCAT Initial Fair Value Of Warrants Upon Issuance
InitialFairValueOfWarrantsUponIssuance
267999 usd
CY2021Q1 RCAT Number Of Warrants Upon Issuance
NumberOfWarrantsUponIssuance
675000 shares
CY2021Q1 RCAT Initial Fair Value Of Warrants Upon Issuance
InitialFairValueOfWarrantsUponIssuance
2870666 usd
CY2022Q2 RCAT Exercise Of Warrants Shares
ExerciseOfWarrantsShares
268332 shares
CY2021Q2 RCAT Warrants To Purchase Shares Issued
WarrantsToPurchaseSharesIssued
200000 shares
CY2021Q2 RCAT Warrants Issued Exercise Price
WarrantsIssuedExercisePrice
5.00
CY2021Q4 RCAT Warrants To Purchase Shares Issued
WarrantsToPurchaseSharesIssued
533333 shares
CY2021Q4 RCAT Warrants Issued Exercise Price
WarrantsIssuedExercisePrice
5.625
CY2023Q4 RCAT Warrants To Purchase Shares Issued
WarrantsToPurchaseSharesIssued
736000 shares
CY2023Q4 RCAT Warrants Issued Exercise Price
WarrantsIssuedExercisePrice
0.625
CY2024Q3 RCAT Warrants To Purchase Shares Issued
WarrantsToPurchaseSharesIssued
750000 shares
CY2024Q3 RCAT Warrants Issued Exercise Price
WarrantsIssuedExercisePrice
6.50
RCAT Number Of Shares Issuable In Connection With Awards Under Plan Maximum
NumberOfSharesIssuableInConnectionWithAwardsUnderPlanMaximum
11750000 shares
RCAT Number Of Shares Issuable In Connection With Awards Under2024 Plan Maximum
NumberOfSharesIssuableInConnectionWithAwardsUnder2024PlanMaximum
11250000 shares
RCAT Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm2
P5Y8M23D
RCAT Unrecognized Stock Based Compensation Expense Related To Unvested Stock Options
UnrecognizedStockBasedCompensationExpenseRelatedToUnvestedStockOptions
2674589 usd
CY2024Q4 RCAT Research And Development Stock Compensation Expense
ResearchAndDevelopmentStockCompensationExpense
80093 usd
CY2023Q4 RCAT Research And Development Stock Compensation Expense
ResearchAndDevelopmentStockCompensationExpense
147629 usd
RCAT Research And Development Stock Compensation Expense
ResearchAndDevelopmentStockCompensationExpense
174515 usd
RCAT Research And Development Stock Compensation Expense
ResearchAndDevelopmentStockCompensationExpense
275046 usd
CY2024Q4 RCAT Sales And Marketing Stock Compensation Expense
SalesAndMarketingStockCompensationExpense
130264 usd
CY2023Q4 RCAT Sales And Marketing Stock Compensation Expense
SalesAndMarketingStockCompensationExpense
208903 usd
RCAT Sales And Marketing Stock Compensation Expense
SalesAndMarketingStockCompensationExpense
246807 usd
RCAT Sales And Marketing Stock Compensation Expense
SalesAndMarketingStockCompensationExpense
374212 usd
CY2024Q4 RCAT General And Administrative Stock Compensation Expense
GeneralAndAdministrativeStockCompensationExpense
1093680 usd
CY2023Q4 RCAT General And Administrative Stock Compensation Expense
GeneralAndAdministrativeStockCompensationExpense
839793 usd
RCAT General And Administrative Stock Compensation Expense
GeneralAndAdministrativeStockCompensationExpense
2328753 usd
RCAT General And Administrative Stock Compensation Expense
GeneralAndAdministrativeStockCompensationExpense
1458673 usd
CY2024Q4 RCAT Total Stock Compensation Expense
TotalStockCompensationExpense
1304037 usd
CY2023Q4 RCAT Total Stock Compensation Expense
TotalStockCompensationExpense
1196325 usd
RCAT Total Stock Compensation Expense
TotalStockCompensationExpense
2750075 usd
RCAT Total Stock Compensation Expense
TotalStockCompensationExpense
2107931 usd
RCAT Stock Compensation Expense Pertaining To Options
StockCompensationExpensePertainingToOptions
815632 usd
RCAT Stock Compensation Expense Pertaining To Options
StockCompensationExpensePertainingToOptions
1606305 usd
RCAT Stock Compensation Expense Pertaining To Restricted Stock Units
StockCompensationExpensePertainingToRestrictedStockUnits
1934443 usd
RCAT Stock Compensation Expense Pertaining To Restricted Stock Units
StockCompensationExpensePertainingToRestrictedStockUnits
501626 usd

Files In Submission

Name View Source Status
0001554795-24-000344-index-headers.html Edgar Link pending
0001554795-24-000344-index.html Edgar Link pending
0001554795-24-000344.txt Edgar Link pending
0001554795-24-000344-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R72.htm Edgar Link pending
R73.htm Edgar Link pending
R74.htm Edgar Link pending
R75.htm Edgar Link pending
R76.htm Edgar Link pending
R77.htm Edgar Link pending
R78.htm Edgar Link pending
R79.htm Edgar Link pending
R8.htm Edgar Link pending
R80.htm Edgar Link pending
R81.htm Edgar Link pending
R9.htm Edgar Link pending
rcat-20241031.xsd Edgar Link pending
rcat1216form10q.htm Edgar Link pending
rcat1216form10qexh31_1.htm Edgar Link pending
rcat1216form10qexh31_2.htm Edgar Link pending
rcat1216form10qexh32_1.htm Edgar Link pending
rcat1216form10qexh32_2.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
rcat-20241031_def.xml Edgar Link unprocessable
rcat-20241031_lab.xml Edgar Link unprocessable
rcat-20241031_pre.xml Edgar Link unprocessable
rcat1216form10q_htm.xml Edgar Link completed
rcat-20241031_cal.xml Edgar Link unprocessable